Scarica l'app Stockscreener
3.58
4.68%
0.16
Dopo l'orario di chiusura:
3.59
0.010
+0.28%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.42
Aprire:
$3.44
Volume 24 ore:
1.78M
Relative Volume:
1.38
Capitalizzazione di mercato:
$618.76M
Reddito:
-
Utile/perdita netta:
$-54.70M
Rapporto P/E:
-10.85
EPS:
-0.33
Flusso di cassa netto:
$-51.36M
1 W Prestazione:
+9.48%
1M Prestazione:
+39.30%
6M Prestazione:
+49.79%
1 anno Prestazione:
-18.82%
Intervallo 1D:
$3.39
$3.635
Intervallo di 1 settimana:
$3.1941
$3.635
Portata 52W:
$1.89
$4.70
Savara Inc Stock (SVRA) Company Profile
Nome
Savara Inc
Settore
Industria
Telefono
51285113796
Indirizzo
6836 BEE CAVE ROAD, AUSTIN, TX
Confronta SVRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SVRA
Savara Inc
|
3.58 | 572.09M | 0 | -54.70M | -51.36M | -0.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Savara Inc Stock (SVRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-15 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-05-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-12-20 | Iniziato | Wells Fargo | Overweight |
| 2024-11-13 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-02-15 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-11-07 | Iniziato | Guggenheim | Buy |
| 2023-05-16 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-03-31 | Downgrade | Jefferies | Buy → Hold |
| 2021-03-16 | Iniziato | Piper Sandler | Overweight |
| 2021-03-15 | Iniziato | Oppenheimer | Outperform |
| 2019-06-13 | Reiterato | H.C. Wainwright | Buy |
| 2019-06-13 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-13 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2018-08-13 | Ripresa | ROTH Capital | Neutral |
| 2018-01-03 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-09-27 | Ripresa | ROTH Capital | Buy |
| 2017-09-22 | Iniziato | Jefferies | Buy |
| 2017-09-11 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Savara Inc Borsa (SVRA) Ultime notizie
Sector ETF performance correlation with Savara Inc.Weekly Gains Report & Community Trade Idea Sharing - Newser
What high frequency data says about Savara Inc.GDP Growth & AI Forecast Swing Trade Picks - Newser
Will Savara Inc. continue its uptrendWeekly Investment Recap & Smart Investment Allocation Tips - Newser
Savara’s Expanding aPAP Market and Strategic Moves Justify Buy Rating with Increased Price Target - TipRanks
Will Savara Inc. stock go up soonTrade Volume Summary & Short-Term High Return Ideas - Newser
Savara Inc. stock chart pattern explained2025 Trade Ideas & Weekly Hot Stock Watchlists - Newser
Market reaction to Savara Inc.’s recent newsQuarterly Trade Summary & Daily Price Action Insights - Newser
Comparing Savara Inc. in custom built stock radarsJuly 2025 Movers & Safe Capital Growth Tips - Newser
Is Savara Inc. stock poised for growth2025 EndofYear Setup & Technical Confirmation Alerts - Newser
How institutional ownership impacts Savara Inc. stockEarnings Growth Report & Free Expert Verified Stock Movement Alerts - Newser
Savara Highlights MOLBREEVI Development in New Presentation - TipRanks
Regression analysis insights on Savara Inc. performance2025 Key Highlights & Stepwise Swing Trade Plans - Newser
Will a bounce in Savara Inc. offer an exitJuly 2025 Breakouts & Real-Time Market Trend Scan - Newser
Savara Announces New U.S. Health Claims Data Analysis Finds Over 50% Increase in the Estimated Numbe - PharmiWeb.com
Trend analysis for Savara Inc. this weekJuly 2025 Market Mood & Stepwise Swing Trade Plans - Newser
Does Savara Inc. stock reflect fundamentals2025 Market WrapUp & Weekly Top Gainers Trade List - khodrobank.com
50% Jump in Rare Lung Disease Patients: Savara Finds 5,500 U.S. Cases Ahead of FDA Drug Review - Stock Titan
What candlestick patterns are forming on Savara Inc.Watch List & Momentum Based Trading Ideas - Newser
Savara’s SWOT analysis: molbreevi’s potential reshapes rare respiratory stock outlook - Investing.com
Earnings Chart Overlay Points to Savara Inc. Upside getLinesFromResByArray error: size == 0 - kangso.co.kr
Will Savara Inc. announce a stock split2025 Technical Overview & Precise Swing Trade Alerts - khodrobank.com
Quant Funds Rotate Into Savara Inc. StockJuly 2025 Summary & Verified High Yield Trade Plans - beatles.ru
Earnings visualization tools for Savara Inc.Weekly Profit Report & Daily Volume Surge Trade Alerts - Newser
Published on: 2025-08-31 18:39:16 - Newser
Long term hold vs stop loss in Savara Inc.2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - Newser
Published on: 2025-09-01 23:59:49 - Newser
Best data tools to analyze Savara Inc. stockRisk Management & Weekly High Conviction Ideas - Newser
What technical models suggest about Savara Inc.’s comebackShare Buyback & AI Enhanced Market Trend Forecasts - Newser
Why Savara Inc. stock attracts strong analyst attention2025 Technical Patterns & Long-Term Safe Investment Plans - Newser
Using flow based indicators on Savara Inc.2025 Macro Impact & Reliable Volume Spike Trade Alerts - Newser
Order flow analysis tools used on Savara Inc.July 2025 Institutional & Stepwise Swing Trade Plans - Newser
Savara Inc. Building a Base Near Support getLinesFromResByArray error: size == 0 - kangso.co.kr
Savara Inc Azioni (SVRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Savara Inc Azioni (SVRA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| McCracken Joseph S | Director |
May 29 '25 |
Buy |
2.08 |
10,000 |
20,825 |
260,837 |
| RAMSAY DAVID A | Director |
Mar 31 '25 |
Buy |
2.77 |
150,000 |
416,250 |
2,513,642 |
| Lowrance David L | Chief Financial Officer |
Dec 16 '24 |
Sale |
3.33 |
25,000 |
83,278 |
381,005 |
| Pauls Matthew | CHIEF EXECUTIVE OFFICER |
Dec 16 '24 |
Sale |
3.31 |
54,702 |
180,828 |
1,536,379 |
| Hawkins Richard J | Director |
Dec 16 '24 |
Sale |
3.32 |
8,000 |
26,569 |
67,241 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):